Found 470 articles for: "atopic dermatitis"
Comparison of Pediatric Dermatology Conditions Across Telehealth and In-Person Visits During the COVID-19 Pandemic
November 2022 | Volume 21 | Issue 11 | Features | 1260 | Copyright © November 2022
Understanding the utility of virtual visits in pediatric dermatology practice has become increasingly important in the telehealth era. We compared the conditions diagnosed in pediatric dermatology bet...
Read MoreMeasuring and Improving Adherence to Crisaborole 2% Ointment in Patients With Atopic Dermatitis
October 2022 | Volume 21 | Issue 10 | Original Article | 1043 | Copyright © October 2022
Background: Atopic dermatitis (AD) is an inflammatory skin condition with dry, scaly, and intensely itchy skin. Treatment failure is the result of poor adherence.
Object...
Read MoreTreatment and Maintenance of Cutaneous Rosacea in Latino Skin Types With Prescription Medications and Non-Prescription Cleansers and Moisturizers as Adjuncts: A Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1111 | Copyright © October 2022
Background: Rosacea is an inflammatory dermatosis with at least a ten percent prevalence reported among white adults. Rosacea occurs in nonwhite populations, but prevalence data is li...
Read MoreThe Role of Antihistamines and Dupilumab in the Management of Alopecia Areata: A Systematic Review
October 2022 | Volume 21 | Issue 10 | Original Article | 1070 | Copyright © October 2022
Background: Approximately 30% to 40% of alopecia areata (AA) patients have atopic dermatitis. Studies suggest that antihistamines and dupilumab may be effective treatments; however, t...
Read MorePhase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis
October 2022 | Volume 21 | Issue 10 | Original Article | 1091 | Copyright © October 2022
Background: Atopic dermatitis is a common skin disorder for which there remains an unmet need for topical pharmacotherapies that are safe and effective. This phase 2 study assessed th...
Read MoreEvolving Concepts in Psoriasis: Special Considerations for Patients With Skin of Color, Skin Barrier Dysfunction, and the Role of Adjunctive Skin Care
October 2022 | Volume 21 | Issue 10 | Original Article | 1054 | Copyright © October 2022
Background: Despite considerable advances in our understanding of the pathogenesis and treatment of psoriasis, data pertaining to racial/ethnic variations, effects on barrier function...
Read MoreArtificial Intelligence in Hair and Nail Disorders
October 2022 | Volume 21 | Issue 10 | Original Article | 1049 | Copyright © October 2022
Artificial intelligence (AI), a field of computer science, aims at simulating human intelligence with computers. Though AI has surpassed dermatologists in skin cancer detection, it still lags behind v...
Read MoreWhy Does Facial Eczema Differ From Body Eczema?
October 2022 | Volume 21 | Issue 10 | Case Reports | 1119 | Copyright © October 2022
Background: The pathophysiology of atopic dermatitis (AD) is multifactorial, influenced by genetics, skin barrier dysfunction, and environmental stressors. There is a lack of research...
Read MoreAnnual Trends in Medicare Part D Prescription Claims for Dupilumab 2017 to 2019
October 2022 | Volume 21 | Issue 10 | Editorials | 1138 | Copyright © October 2022
Disease control for moderate to severe atopic dermatitis (AD) has been primarily achieved with phototherapy and non-specific immunomodulators, cyclosporine, and methotrexate. These treatments have, ho...
Read MoreDermal Safety of Tapinarof Cream 1%: Results From 4 Phase 1 Trials
October 2022 | Volume 21 | Issue 10 | Original Article | 1084 | Copyright © October 2022
Background: Tapinarof (VTAMA®; Dermavant Sciences, Inc.) is a novel, non-steroidal, topical, aryl hydrocarbon receptor agonist, FDA approved for psoriasis treatment and...
Read MoreSupplement Article: Skin Barrier Deficiency in Rosacea: An Algorithm Integrating OTC Skincare Products Into Treatment Regimens
September 2022 | Volume 21 | Issue 9 | Supplement Individual Articles | SF3595563 | Copyright © September 2022
Introduction: Rosacea is a chronic condition involving inflammation leading to a diminished skin barrier function in sebaceous gland-rich facial skin. The current algorithm represents...
Read MoreSupplement Article: The Role of Epidermal Barrier Dysfunction and Cutaneous Microbiome Dysbiosis in the Pathogenesis and Management of Acne Vulgaris and Rosacea
September 2022 | Volume 21 | Issue 9 | Supplement Individual Articles | SF3502915 | Copyright © September 2022
Background: Dysregulation of either the cutaneous microbiome (CM) or epidermal barrier function (EBF) is thought to play an increasingly important role in acne vulgaris (AV) and rosac...
Read MoreSupplement Article: Dysbiosis, (Barrier) Dysfunction, and Dermatoses: A Chicken-and-Egg Dilemma
September 2022 | Volume 21 | Issue 9 | Supplement Individual Articles | SF3502913 | Copyright © September 2022
Acne vulgaris (AV) and rosacea are two of the most common dermatoses diagnosed and managed by dermatologists.1,2 Despite this and our improved understanding of the unique pathogenesis of ea...
Read MoreEfficacy, Safety, and Applications of Skin Protectants
September 2022 | Volume 21 | Issue 9 | Original Article | 977 | Copyright © September 2022
The skin barrier is essential for protection against allergens, irritants, and pathogens and is intimately involved in a variety of inflammatory conditions. As such, approaches to treating these infla...
Read MoreNontraditional Healing Utilization and Disclosure Among Dermatology Patients: A National Cross-Sectional Survey Study
September 2022 | Volume 21 | Issue 9 | Editorials | 1015 | Copyright © September 2022
Nontraditional healing (NTH) consists of spiritual and religious healing (SRH) and complementary and alternative medicine (CAM). SRH includes faith healing, prayer, and meditation. CAM includes use of...
Read MoreVehicle Formulation Impacts Tolerability and Patient Preference: Comparison of Tretinoin Branded Lotion and Generic Cream
August 2022 | Volume 21 | Issue 8 | Original Article | 875 | Copyright © August 2022
Background: Topical retinoids like tretinoin are a mainstay of acne treatment but associated cutaneous irritation and drying may lead to poor adherence. As vehicle optimization can im...
Read MoreUnmet Needs in Psoriasis Patients
August 2022 | Volume 21 | Issue 8 | Original Article | 839 | Copyright © August 2022
Background: Psoriasis can greatly impact patients' quality of life. The introduction of new treatments has improved treatment outcomes, but treatment gaps may still exist.
Read More International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting
August 2022 | Volume 21 | Issue 8 | Original Article | 867 | Copyright © August 2022
Background: International Dermatology Outcome Measures (IDEOM) is a non-profit organization founded in 2013. It is composed of researchers and stakeholders who work to develop evidenc...
Read MoreOnset of Plaque Psoriasis Treatment Responses With Anti-IL-17/IL-23 Biologic Therapies
August 2022 | Volume 21 | Issue 8 | Original Article | 854 | Copyright © August 2022
Background: The impact of psoriasis on quality of life arises from both physical symptoms, such as pain and pruritus, and the psychosocial effects of the often highly visible lesions....
Read MoreUsage of Topical Calcineurin Inhibitors in the Medicare Population from 2013 to 2018
August 2022 | Volume 21 | Issue 8 | Editorials | 912 | Copyright © August 2022
Topical calcineurin inhibitors are a family of drugs that have been touted for having high efficacy without the risks of cutaneous atrophy and systemic absorption seen with topical corticosteroids. Th...
Read More